View Older Stories View More Recent Stories

Feb 12, 2018 04:15PM Form SC 13G CATALYST BIOSCIENCES, Filed by: venBio Select Advisor LLC
Feb 12, 2018 04:14PM Form SC 13G Teligent, Inc. Filed by: venBio Select Advisor LLC
Feb 12, 2018 04:14PM Form SC 13G ASSEMBLY BIOSCIENCES, Filed by: venBio Select Advisor LLC
Feb 12, 2018 04:11PM Form SC 13G VIVEVE MEDICAL, INC. Filed by: venBio Select Advisor LLC
Feb 12, 2018 04:10PM Form SC 13G/A IOVANCE BIOTHERAPEUTICS, Filed by: venBio Select Advisor LLC
Feb 9, 2018 12:04PM Form SC 13G Apellis Pharmaceuticals, Filed by: venBio Global Strategic Fund II L.P.
Feb 9, 2018 12:03PM Form SC 13G/A Nabriva Therapeutics Filed by: venBio Global Strategic Fund II L.P.
Feb 8, 2018 11:55AM Form SC 13D Menlo Therapeutics Inc. Filed by: venBio Global Strategic Fund II L.P.
Jan 29, 2018 04:24PM Form 4 Menlo Therapeutics, Inc. For: Jan 25 Filed by: venBio Global Strategic Fund II L.P.
Jan 24, 2018 07:07PM Form 3 Menlo Therapeutics, Inc. For: Jan 24 Filed by: venBio Global Strategic Fund II L.P.
Jan 4, 2018 07:27AM Neurogastrx, Inc. Raises $45M Series A To Bring Lead GI Candidate Through Proof Of Concept
Dec 7, 2017 05:00AM Metacrine Completes Series B Financing to Advance Best-in-Class FXR Program into Clinical Development
Nov 16, 2017 11:47AM Form 4 IMMUNOMEDICS INC For: Nov 14 Filed by: venBio Select Advisor LLC
Nov 15, 2017 05:30PM Form SC 13D/A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Nov 14, 2017 12:23PM Form 13F-HR venBio Select Advisor For: Sep 30
Nov 13, 2017 04:28PM Form 4 Apellis Pharmaceuticals, For: Nov 13 Filed by: venBio Global Strategic Fund II L.P.
Nov 9, 2017 04:10PM Immunomedics Announces First Quarter Fiscal 2018 Results and Provides Corporate Update
Nov 8, 2017 08:35PM Form 3 Apellis Pharmaceuticals, For: Nov 08 Filed by: venBio Global Strategic Fund II L.P.
Oct 26, 2017 03:05PM Schulte Roth & Zabel Holds 8th Annual Shareholder Activism Conference
Oct 11, 2017 02:12PM Form D/A venBio Select Fund Ltd.
Oct 11, 2017 02:09PM Form D/A venBio Select Fund LLC
Oct 6, 2017 04:00AM Harmony Biosciences Acquires US Rights to Pitolisant From Bioprojet; Raises $270 Million in Equity Financing
Oct 3, 2017 12:17PM Form SC 13G/A Mirati Therapeutics, Filed by: venBio Select Advisor LLC
Sep 18, 2017 09:00AM Serlopitant Pruritus Reduction Results from Two Phase 2 Studies Presented at the 26th European Academy of Dermatology and Venereology
Aug 16, 2017 04:00PM Immunomedics Announces Fiscal 2017 Results and Strategic Developments; Reiterates Guidance on BLA Submission Timeline
Aug 14, 2017 12:31PM Form 13F-HR venBio Select Advisor For: Jun 30
Aug 10, 2017 09:01AM Apellis Pharmaceuticals Announces $60 Million Series E Financing
Jul 18, 2017 08:00AM Menlo Therapeutics Raises $50M
Jul 6, 2017 06:08AM Form SC 13G Aurinia Pharmaceuticals Filed by: venBio Global Strategic Fund, L.P.
Jul 5, 2017 05:57PM venBio Global Strategic Fund, L.P. Announces Update to Stake in Aurinia Pharmaceuticals Inc.
Jun 15, 2017 04:44PM Checkmate Pharmaceuticals Secures $27 Million Series B Preferred Financing and Appoints Karen Brennan as Chief Operating Officer
Jun 8, 2017 05:00PM Fennec Announces $7.6 Million Private Placement of Common Shares Led by venBio Select Advisor
May 24, 2017 12:54PM Schulte Roth & Zabel Hosts Seminar: Shareholder Activism in the UK
May 15, 2017 12:20PM Form 13F-HR venBio Select Advisor For: Mar 31
May 9, 2017 11:33AM Form SC 13D/A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
May 8, 2017 05:11PM Form SC 13G Verona Pharma plc Filed by: venBio Global Strategic Fund II L.P.
May 5, 2017 08:49AM Immunomedics (IMMU) Announces $125M Private Placement of Convertible Preferred Stock; Outlines Strategic Steps to Drive Stockholder Value; CEO to Step Down
May 5, 2017 08:46AM Immunomedics Delivers Business Updates, Announces Private Placement Offering and Outlines Strategic Steps to Drive Stockholder Value
Mar 17, 2017 05:16PM Form SC 13D/A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Mar 3, 2017 12:00PM Stockholders Endorse venBio’s Case for Meaningful Change at Immunomedics
Mar 3, 2017 10:19AM Immunomedics Board Institutes Measures As Stockholder Fiduciaries To Preserve Their Best Business Judgment To Protect The Rights Of All Stockholders
Mar 2, 2017 05:01PM Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Mar 2, 2017 01:52PM venBio Encourages Stockholders to Vote for Change at Immunomedics (IMMU)
Mar 2, 2017 01:51PM venBio Encourages Stockholders to Vote for Change
Mar 2, 2017 10:24AM Immunomedics (IMMU) Says Revised Settlement Offer Rejected By venBio
Mar 2, 2017 10:23AM Immunomedics Outlines Revised Settlement Offer Rejected By venBio; Announces Actions That Are In The Best Interests Of All Stockholders
Mar 2, 2017 06:02AM Form D/A venBio Global Strategic
Feb 27, 2017 08:00AM Immunomedics Issues Open Letter Highlighting the Clear Decision to Vote for Immunomedics to Ensure Continued Value Creation
Feb 22, 2017 05:05PM Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Feb 22, 2017 08:32AM venBio Sends Letter to Immunomedics Stockholders
View More Recent Stories View Older Stories